Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder
International Journal of Molecular Sciences · 07.04.2023 · 24 (8) · 6888
DOI: 10.3390/ijms24086888 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.04.2023. Verfasst von Maja Jazvinšćak Jembrek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička 54, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 304 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Major depressive disorder is one of the most common mental illnesses that highly impairs quality of life. Pharmacological interventions are mainly focused on altered monoamine neurotransmission, which is considered the primary event underlying the disease’s etiology. However, many other neuropathological mechanisms that contribute to the disease’s progression and clinical symptoms have been identified. These include oxidative stress, neuroinflammation, hippocampal atrophy, reduced synaptic plasticity and neurogenesis, the depletion of neurotrophic factors, and the dysfunction of the hypothalamic–pituitary–adrenal (HPA) axis. Current therapeutic options are often unsatisfactory and associated with adverse effects. This review highlights the most relevant findings concerning the role of flavonols, a ubiquitous class of flavonoids in the human diet, as potential antidepressant agents. In general, flavonols are considered to be both an effective and safe therapeutic option in the management of depression, which is largely based on their prominent antioxidative and anti-inflammatory effects. Moreover, preclinical studies have provided evidence that they are capable of restoring the neuroendocrine control of the HPA axis, promoting neurogenesis, and alleviating depressive-like behavior. Although these findings are promising, they are still far from being implemented in clinical practice. Hence, further studies are needed to more comprehensively evaluate the potential of flavonols with respect to the improvement of clinical signs of depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička 54, 10000 Zagreb, Croatia.
- School of Medicine, Catholic University of Croatia, Ilica 242, 10000 Zagreb, Croatia.
- Division of Animal Physiology, Faculty of Science, University of Zagreb, Rooseveltov trg 6, 10000 Zagreb, Croatia.
- Department of Psychiatry, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
ORCID-Profile: Maja Jazvinšćak Jembrek, Nada Oršolić, Dalibor Karlović, Vjekoslav Peitl
Zitieren
APA
Jazvinšćak Jembrek, M., Oršolić, N., Karlović, D., & Peitl, V. (2023). Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder. International Journal of Molecular Sciences, 24(8), 6888. https://doi.org/10.3390/ijms24086888
Vancouver
Jazvinšćak Jembrek M, Oršolić N, Karlović D, Peitl V. Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder. International Journal of Molecular Sciences. 2023;24(8):6888. doi:10.3390/ijms24086888
BibTeX
@article{JazvinakJembrek2023,
author = {Jazvinšćak Jembrek, Maja and Oršolić, Nada and Karlović, Dalibor and Peitl, Vjekoslav},
title = {Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {6888},
doi = {10.3390/ijms24086888}
}
EUVIMED